TCMDライブシグナル | Getagraph.comで利益を最大化

売る 108121 min ago

@ $15.16

発行日: 14 2月 2024 @ 23:42

リターン: -6.33%

前回のシグナル: 2月 13 - 04:20

前回のシグナル: 買う

リターン: -2.51 %

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:40):

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States...

Stats
本日の出来高	59 427.00
平均出来高	294 533
時価総額	337.38M
EPS	$0 ( 2024-02-20 )
次の収益日	( $-0.110 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	11.54
ATR14	$0.0240 (0.17%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-27	Burns Kristie	Sell	1 091	Common Stock
2024-02-29	Burns Kristie	Sell	243	Common Stock
2024-02-27	Reuvers Daniel L.	Sell	4 689	Common Stock
2024-02-29	Reuvers Daniel L.	Sell	1 396	Common Stock
2024-02-24	Reuvers Daniel L.	Buy	13 100	Common Stock

INSIDER POWER
80.61
Last 93 transactions
Buy: 671 413 \| Sell: 92 622

ボリューム相関

長: 0.00 (neutral)

短: -0.89 (strong negative)

Signal:(52.767) Neutral

Tactile Systems 相関

10 最も正の相関
CIIG	0.979
ACAB	0.978
CBRG	0.976
FNVT	0.972
MITA	0.969
ALPA	0.968
FIAC	0.968
GMFI	0.968
ADAL	0.967
GLLI	0.967

10 最も負の相関
TIVC	-0.965
ASPS	-0.961
CREG	-0.956
LGMK	-0.955
HOL	-0.955
EVLO	-0.954
NKTX	-0.954
SVAC	-0.952
EPSN	-0.951
RPID	-0.95

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Tactile Systems 相関 - 通貨/商品

-0.62
( weak negative )

-0.71
( moderate negative )

0.00
( neutral )

-0.60
( weak negative )

0.28
( neutral )

0.58
( weak )

Tactile Systems 財務諸表

Annual	2023
収益:	$274.42M
総利益:	$195.13M (71.11 %)
EPS:	$1.240

FY	2023
収益:	$274.42M
総利益:	$195.13M (71.11 %)
EPS:	$1.240

FY	2022
収益:	$246.79M
総利益:	$175.98M (71.31 %)
EPS:	$-0.890

FY	2021
収益:	$208.06M
総利益:	$148.21M (71.24 %)
EPS:	$-0.600

Financial Reports:

No articles found.

Tactile Systems

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.